ID
26274
Beschreibung
Study ID: 101468/196 Clinical Study ID: 101468/196 Study Title: 101468/196: A Long-Term, Open-Label Continuation Study of Once Daily Administration of Ropinirole CR Tablets to Patients with Parkinson's Disease who Completed the Previous Ropinirole CR Studies 167 or 164 Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00650104 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Parkinson DiseaseA Long-Term, Open-Label Continuation Study of Once Daily Adminstration of Ropinirole CR Tablets to Patients with Parkinson's Disease Who Completed the Previous Ropinirole CR Studies - 167 & 164 Ongoing Record: Adverse Events
Stichworte
Versionen (1)
- 15.10.17 15.10.17 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
15. Oktober 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC-ND 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Adverse Events Ropinirole in Parkinson's Disease GSK 101468/196
Adverse Events Ropinirole in Parkinson's Disease GSK 101468/196
- StudyEvent: ODM
Beschreibung
Adverse Events
Alias
- UMLS CUI-1
- C0877248
Beschreibung
If YES, indicate below.
Datentyp
boolean
Alias
- UMLS CUI [1]
- C0877248
Beschreibung
Adverse Event Diagnosis
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0011900
Beschreibung
* A Serious Adverse Event is any AE that is fatal, life-threatening , disabling/incapacitating, results in inpatient hospitalization or prolongation of existing hospitalization, or a congenital anomaly/birth defect. Important medical events that may not result in death, be life-threatening, or require hospitalization may be considered a serious adverse drug experience when, based upon appropriate medical judgement, they may jeopardise the patient and may require medical or surgical intervention to prevent one of the outcomes listed in this definition. Cancer, overdose and pregnancy must also be reported on SAE form. Record any Serious Adverse Events on the Serious Adverse Event from and notify the PAREXEL Clinical Trial Safety Center within 24 hours of learning of its occurence
Datentyp
boolean
Alias
- UMLS CUI [1]
- C1710056
Beschreibung
Start Date
Datentyp
date
Maßeinheiten
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C0808070
Beschreibung
Start Time
Datentyp
time
Maßeinheiten
- 24hr:min
Alias
- UMLS CUI [1]
- C1301880
Beschreibung
If ongoing, please eave blank.
Datentyp
date
Maßeinheiten
- dd-mmm-yyyy
Alias
- UMLS CUI [1]
- C0806020
Beschreibung
End Time
Datentyp
time
Maßeinheiten
- 24hr:min
Alias
- UMLS CUI [1]
- C1522314
Beschreibung
Adverse Event: Intensity
Datentyp
integer
Alias
- UMLS CUI [1]
- C1710066
Beschreibung
Relationship to Drug
Datentyp
integer
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0013230
- UMLS CUI [1,3]
- C0439849
Beschreibung
Action Taken
Datentyp
integer
Alias
- UMLS CUI [1]
- C2826626
Beschreibung
If YES, record on Other (non-study) Medications Form.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0087111
Beschreibung
Event Course
Datentyp
text
Alias
- UMLS CUI [1,1]
- C0877248
- UMLS CUI [1,2]
- C0750729
Beschreibung
Number of Adverse Events
Datentyp
float
Alias
- UMLS CUI [1,1]
- C1519255
- UMLS CUI [1,2]
- C0449788
Beschreibung
Adverse Event Outcome
Datentyp
integer
Ähnliche Modelle
Adverse Events Ropinirole in Parkinson's Disease GSK 101468/196
- StudyEvent: ODM
C0011900 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
C0439849 (UMLS CUI [1,3])
C0087111 (UMLS CUI [1,2])
C0750729 (UMLS CUI [1,2])
C0449788 (UMLS CUI [1,2])